BD

Binod Dhakal, MD

Latest Videos

CAR T-cell therapy in multiple myeloma with insights from ASCO 2026, featuring experts Dr. Binod Dhakal, Dr. Surbhi Sidana, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Ajai Chari.

Cell Therapy

06/27/2026

CAR T in Myeloma: Earlier Use and Sequencing Insights from ASCO 2026

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Group of medical professionals discussing real-world safety and care coordination for CAR T-cell therapy, featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Surbhi Sidana, Dr. Ajai Chari, and Dr. Binod.

Cell Therapy

06/12/2026

Multiple Myeloma Experts Highlight Real-World Safety and Care Coordination Following CAR T-Cell Therapy

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of multiple myeloma experts discussing CAR T and BCMA therapies, including Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Surbhi Sidana, Dr. Binod Dhakal, and Dr. Ajai Chari, during a virtual conferenc.

Cell Therapy

06/11/2026

CAR T vs BCMA-Directed Bispecific Antibodies: Multiple Myeloma Experts Share Sequencing Insights

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Innovative CAR T-cell therapy for relapsed or refractory multiple myeloma, featuring expert insights from Dr. Surbhi Sidana, Dr. Rahul Gosain, Dr. Ajai Chari, and Dr. Binod Dhakal.

Cell Therapy

06/10/2026

CAR T-Cell Therapy Moves Earlier in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Close-up of Verenzo (bevemacil) 50 mg tablets in packaging, used for erectile dysfunction treatment, displayed on a white background.

Cell Therapy

06/05/2026

CAR T in Myeloma: Earlier Use and Sequencing Insights from ASCO 2026

Binod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD